Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy B Cook

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Blood|October 19, 2020
How I treat adult T-cell leukemia/lymphomaLucy B Cook, Adrienne A Phillips
Current Opinion in Infectious Diseases|September 19, 2015
Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?Lucy B Cook, Graham P Taylor
British Journal of Haematology|July 15, 2022
A new paradigm for the management of ATLGraham P Taylor, Lucy B Cook
Seminars in Cancer Biology|December 10, 2013
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infectionCharles R M Bangham, Lucy B Cook, Anat Melamed
Leukemia Research|December 6, 2024
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)Devon A Weterings, Aileen G Rowan, Lucy B Cook
Virology|December 11, 2012
HTLV-1: persistence and pathogenesisLucy B Cook, Marjet Elemans, Aileen G Rowan, et al.
Blood|September 8, 2012
HTLV-1-infected T cells contain a single integrated provirus in natural infectionLucy B Cook, Aileen G Rowan, Anat Melamed, et al.
British Journal of Haematology|June 28, 2020
Ruxolitinib for tocilizumab-refractory severe COVID-19 infectionAndrew J Innes, Lucy B Cook, Sasha Marks, et al.
Blood|April 17, 2014
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphomaLucy B Cook, Anat Melamed, Heather Niederer, et al.
International Journal of Hematology|November 2, 2017
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphomaLucy B Cook, Aileen G Rowan, Maria A Demontis, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Blood|October 19, 2020
How I treat adult T-cell leukemia/lymphomaLucy B Cook, Adrienne A Phillips
Current Opinion in Infectious Diseases|September 19, 2015
Treatment of adult T-cell leukaemia/lymphoma: is the virus a target?Lucy B Cook, Graham P Taylor
British Journal of Haematology|July 15, 2022
A new paradigm for the management of ATLGraham P Taylor, Lucy B Cook
Seminars in Cancer Biology|December 10, 2013
HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infectionCharles R M Bangham, Lucy B Cook, Anat Melamed
Leukemia Research|December 6, 2024
Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)Devon A Weterings, Aileen G Rowan, Lucy B Cook
Virology|December 11, 2012
HTLV-1: persistence and pathogenesisLucy B Cook, Marjet Elemans, Aileen G Rowan, et al.
Blood|September 8, 2012
HTLV-1-infected T cells contain a single integrated provirus in natural infectionLucy B Cook, Aileen G Rowan, Anat Melamed, et al.
British Journal of Haematology|June 28, 2020
Ruxolitinib for tocilizumab-refractory severe COVID-19 infectionAndrew J Innes, Lucy B Cook, Sasha Marks, et al.
Blood|April 17, 2014
The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia/lymphomaLucy B Cook, Anat Melamed, Heather Niederer, et al.
International Journal of Hematology|November 2, 2017
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphomaLucy B Cook, Aileen G Rowan, Maria A Demontis, et al.
Pageof 2